Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

Clinical trial NCT02695004 · COMPLETED

Trial details

NCT number: NCT02695004
Sponsor: Dongkook Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2016-02-01
Primary completion: 2017-03-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.